BioHarvest Sciences is a biotechnology company that grows plant cells in bioreactors to produce concentrated active compounds from fruits and plants, without growing the whole plant. Its core technology, called Botanical Synthesis, establishes a cell bank from a physical plant, then replicates those cells in large bioreactors to produce a powdered output with higher concentrations of active ingredients than found in nature. The primary commercial product is VINIA, a red grape cell powder rich in polyphenols — particularly piceid resveratrol — marketed as a cardiovascular and energy supplement. BioHarvest sells VINIA predominantly D2C through vinia.com (subscription-based) and Amazon, with subscriptions representing roughly 90% of vinia.com revenue. Beyond the core capsule, BioHarvest embeds VINIA into functional coffee pods, tea sachets, chewable supplements, and electrolyte drink powders under a "VINIA Inside" strategy. The company operates two business units: a Products unit (~90%+ of revenue) and a CDMO Services unit, through which BioHarvest develops and manufactures plant-based active molecules for third-party pharmaceutical, nutraceutical, and cosmeceutical companies. CDMO contracts begin with upfront R&D fees and progress toward long-term royalty-based commercial manufacturing. Management's long-term vision is for CDMO to become the majority of revenue. BioHarvest manufactures VINIA powder at its Israeli bioreactor facility, and partners with third-party manufacturers for finished formats like coffee pods and chews.